Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Craftport Cannabis Corp Com C.BBT


Primary Symbol: BHHKF

Benchmark Botanics Inc through its subsidiaries, operates as a producer of medical cannabis. The company provides financing, partnership opportunities and acquisition offers to licensed producers and ancillary businesses within the cannabis industry. It operates approximately 12,000 square foot production facility in Peachland, British Columbia.


OTCPK:BHHKF - Post by User

Post by STOCKRUSon Nov 12, 2019 11:13pm
25 Views
Post# 30343138

Cannabis Producer - Benchmark Botanics - BBT.C

Cannabis Producer - Benchmark Botanics - BBT.C Investment Highlights
  • Health Canada Licensed Producer and Distributor under the Cannabis Act and its Regulations
  • Medical, Pharmaceutical & Wellness Markets
  • Sales & Revenues, from Peachland Cannabis Complex
  • Peachland Expansion to 62,500 sq. ft
  • Pitt Meadows Greenhouse 174,240 sq. ft
  • Established EU Partnerships for Export
  • Asia-Pacific Markets - JV Zhejiang Yatai Pharmaceutical
  • Over 60 Genetic Strains
  • Closed $11M financing
 
About Benchmark Botanics Inc.

Benchmark Botanics is a diversified multi licensed cannabis producer focused on a three-way vertical business model targeting the medical, pharmaceutical and recreational markets in Canada and the European Union. The company's business plan also includes a strategy to be the first Canadian licensed producer to be selling medical cannabis and hemp throughout Asia through its JV partnership with Zhejiang Yatai Pharmaceutical https://en.yataipharma.com/  which is part of the Yatai Group https://en.yatai.com/ a China based top 500 enterprises.
 
Zhejiang Yatai Pharmaceutical founded in 1989 researches, produces, sells, and exports pharmaceutical products, tablets, capsules, patches, powder injections in China and internationally.
 
Revenue $188.29 M USD 2018
Net Income: $30.1M USD 2018
Market Cap $ 8.525 B USD
803 employees
50 offices in 24 provinces in China
GMP standards / modern pharmaceutical production techniques
2002 ISO 9001 quality certification – ISO 14001 environmental protection
 
 
https://benchmarkbotanics.com/

<< Previous
Bullboard Posts
Next >>